Ingredient news
Short Bowel Syndrome Study Finds Low Choline and Betaine in Children
By Nutranexa News |
A pediatric short bowel syndrome analysis found low plasma choline, betaine, and phosphatidylcholine levels, linking lower choline status with liver-steatosis risk.
What Was Measured
Researchers retrospectively analyzed 127 plasma samples from 80 children with short bowel syndrome managed in an intestinal rehabilitation program.
The study examined plasma choline and related metabolites, including betaine, phosphatidylcholine subgroups, and TMAO, and compared results by parenteral-nutrition status and hepatic steatosis.
Key Findings
The paper reported low plasma choline, betaine, and phosphatidylcholine concentrations overall, with one quarter of patients showing markedly reduced choline and betaine values.
TMAO levels varied widely and were inversely correlated with plasma choline, while the clearest difference between steatotic and non-steatotic patients was lower choline and betaine concentrations.
Buyer Takeaway
The study is a reminder that choline status remains a concrete clinical issue in specialized nutrition settings, not just a label-level discussion point.
The authors call for controlled supplementation trials, which may matter for ingredient suppliers serving pediatric, enteral, or medical-nutrition formulators.